Preserve Access to Affordable Generics and Biosimilars Act

Health Senate 7 cosponsors

Latest action: Read twice and referred to the Committee on the Judiciary. · January 9, 2019

Understand the measure

What this bill does

No official summary is on file here yet. Check Congress.gov for available summaries and the bill text.

Check official summaries ↗

The measure

The official bill title and text published by Congress and GovInfo.

The movement

Every committee, chamber, and clerk-recorded action attached to its date.

The votes

Every roll call on this measure—or a clear notice when no individual vote exists.

Where it stands

The measure's progress

In committee

Read twice and referred to the Committee on the Judiciary.

Recorded January 9, 2019, as the clerk wrote it

Sponsor Sen. Klobuchar, Amy [D-MN]

Committee Judiciary Committee

Recorded votes None taken

The official record

Congress.gov bill page
The bill text, as published by GPO GovInfo
Article I, Section 7 of the Constitution: how a bill becomes law
Status, sponsor and actions from the official GovInfo record, read October 12, 2026 · see sources

Cite this record

Reference number: bill-116-s64
Permanent link: https://votefiles.com/cite/bill-116-s64
Official source: Congress.gov ↗
Last checked: October 12, 2026Status and actions last read from the official GovInfo BILLSTATUS record

AP style

Vote Files, "S. 64 (116th Congress): Preserve Access to Affordable Generics and Biosimilars Act," last checked Oct. 12, 2026, citing Congress.gov, https://votefiles.com/cite/bill-116-s64

APA

Vote Files. (2026, October 12). S. 64 (116th Congress): Preserve Access to Affordable Generics and Biosimilars Act [Bill record]. Retrieved October 15, 2026, from https://votefiles.com/cite/bill-116-s64

Chicago

Vote Files. "S. 64 (116th Congress): Preserve Access to Affordable Generics and Biosimilars Act." Last modified October 12, 2026. Accessed October 15, 2026. https://votefiles.com/cite/bill-116-s64.

BibTeX

@misc{votefiles_bill_116_s64,
  author       = {{Vote Files}},
  title        = {{S. 64 (116th Congress): Preserve Access to Affordable Generics and Biosimilars Act}},
  year         = {2026},
  howpublished = {\url{https://votefiles.com/cite/bill-116-s64}},
  note         = {Reference number bill-116-s64; official source: Congress.gov, https://www.congress.gov/bill/116th-congress/senate-bill/64; last checked October 12, 2026; accessed October 15, 2026}
}

Plain link

https://votefiles.com/cite/bill-116-s64

Cite the official source for the underlying fact. The Vote Files reference number never changes for this record. AP, APA and Chicago are standard citation styles for news and academic writing, and BibTeX is the format reference-manager programs read.

Official analyses

CBO cost estimates and CRS reports on S. 64

Published March 31, 2021Drug Pricing and Intellectual Property: The Legislative Landscape for the 117th Congress (PDF)
CRS · Reports · R46741

Published February 11, 2020Drug Pricing and Pharmaceutical Patenting Practices (PDF)
CRS · Reports · R46221

Listed only where the Congressional Budget Office names this bill number in its estimate's title and that title matches the bill's own, or where the Congressional Research Service lists this bill among a report's related materials. Titles and dates are the publishers' own. All watchdog and scorekeeper reports

On the record

No recorded vote

No roll call has been taken on this measure, so no member's position on it is on the record. Most measures never get one.